Keywords: abraxis, seeks, reacquire, abraxane, marketing, rights, az

Abraxis seeks to reacquire US Abraxane marketing rights from AZ

Article | 01 December 2008

Print This

USA-based Abraxis BioScience has entered into an agreement with Anglo-Swedish drug major AstraZeneca, under which, subject to approval by the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in